COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic’s Impact in Type 1 and Type 2 Diabetes
Author(s) -
Justin M. Gregory,
James C. Slaughter,
Sara H. Duffus,
T. Jordan Smith,
Lauren M. LeStourgeon,
Sarah S. Jaser,
Allison B. McCoy,
James M. Luther,
Erin R. Giovannetti,
Schafer Boeder,
Jeremy Pettus,
Daniel J. Moore
Publication year - 2020
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc20-2260
Subject(s) - medicine , covid-19 , pandemic , type 2 diabetes , diabetes mellitus , betacoronavirus , type 1 diabetes , coronavirus infections , disease , prospective cohort study , severity of illness , coronavirus , intensive care medicine , virology , infectious disease (medical specialty) , endocrinology , outbreak
To quantify and contextualize the risk for coronavirus disease 2019 (COVID-19)-related hospitalization and illness severity in type 1 diabetes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom